DETAILED NOTES ON HTTPS://143316.COM/

This investigate was performed to evaluate the potential on the CPPs with tumor-targeting Attributes to deliver a cytotoxic payload to HCC cells. We explored using a CXCR4-concentrating on peptide, T22, fused with cytotoxic peptide PE24, to be a novel therapeutic strategy for CXCR4+ HCC cells. T22 was selected as the nanocarrier on account of its p